SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The December 2021 quarter revenue stood at Rs. 716.99 millions, up 9.81% as compared to Rs. 652.93 millions during the corresponding quarter last year.The company has announced a 30.16% increase in its profits to Rs . 79.66  millions for the  quarter ended December 2021 compared to Rs. 61.20 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended December 2021 rose to 132.89 millions as compared to 106.01 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 716.99 652.93 9.81 2391.39 1907.13 25.39 2474.50 3207.95 -22.86
Other Income 60.28 48.90 23.27 165.27 126.99 30.14 171.80 71.11 141.60
PBIDT 132.89 106.01 25.36 473.07 252.52 87.34 363.28 374.25 -2.93
Interest 1.04 1.72 -39.53 3.62 4.79 -24.43 6.53 7.96 -17.96
PBDT 131.85 104.29 26.43 469.45 247.73 89.50 356.75 366.29 -2.60
Depreciation 23.13 20.80 11.20 64.17 61.80 3.83 82.32 76.75 7.26
PBT 108.72 83.49 30.22 405.28 185.93 117.97 274.43 289.54 -5.22
TAX 29.06 22.29 30.37 94.46 37.41 152.50 53.01 97.85 -45.83
Deferred Tax 7.28 6.80 7.06 0.85 10.16 -91.63 9.27 -8.10 -214.44
PAT 79.66 61.20 30.16 310.82 148.52 109.28 221.42 191.69 15.51
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 18.53 16.24 14.16 19.78 13.24 49.40 14.68 11.67 25.84

Albert David Share Price

718.20 -7.85 (-1.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×